Dicerna Pharmaceuticals Inc(NASDAQ:DRNA) stock News

DRNA Latest News, Press Relases and Analysis

All

Press Releases

10 months ago - By: Aligos Therapeutics - Mentions: ALGS PLRX NVO HAE

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

2 years ago - By: Investor's Business Daily - Mentions: LLY VERV AMGN ARWR ...

Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million

4 years ago - By: Dicerna Pharmaceuticals, Inc.

Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition

4 years ago - By: Dicerna Pharmaceuticals, Inc.

Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk Tender Offer to Acquire Dicerna

4 years ago - By: Benzinga - Mentions: CINF DOW EW MCK ...

10 Biggest Price Target Changes For Thursday

4 years ago - By: Benzinga - Mentions: BEP BMY EVGO YUM ...

Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021

4 years ago - By: The Motley Fool - Mentions: NVO ARWR

4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout

4 years ago - By: Halper Sadeh LLP - Mentions: COR STXB BCML

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates COR, STXB, BCML, DRNA; Shareholders are Encouraged to Contact the Firm

4 years ago - By: Halper Sadeh LLP - Mentions: RRD LEVL HRC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates DRNA, RRD, LEVL, HRC; Shareholders are Encouraged to Contact the Firm

4 years ago - By: Investor's Business Daily - Mentions: PFE NVS ALNY ARWR ...

How Alnylam Pharmaceuticals Could Take On Pfizer With A 'Catalyst-Rich' 2022

4 years ago - By: Zacks Investment Research - Mentions: GSK NVO EDIT

Novo Nordisk (NVO) Set to Acquire Dicerna for $3.3 Billion

4 years ago - By: WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.

4 years ago - By: Invezz

Dicerna Pharmaceuticals acquired by Novo Nordisk; Shares rocket 80%

4 years ago - By: The Motley Fool - Mentions: NVO

Why Dicerna Pharmaceuticals Stock Is Rocketing Higher Today

4 years ago - By: InvestorPlace - Mentions: PTLO RIVN

PTLO Stock: 8 Reasons Why Portillo’s Investors Feel Like Losing Their Lunch Today

4 years ago - By: InvestorPlace - Mentions: LCID RIVN FSR SEV

LCID, RIVN, FSR: Why Are EV Stocks Down Today?

4 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtained a Fair Price in its going private transaction with Novo Nordisk

4 years ago - By: Halper Sadeh LLP

Dicerna Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Dicerna Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – DRNA

4 years ago - By: InvestorPlace - Mentions: SEV CLOV

DRNA Stock: The $3B Novo Nordisk Deal That Has Dicerna Pharma Shares Skyrocketing Today

4 years ago - By: Investor's Business Daily - Mentions: NVO ALNY

Dicerna Pharmaceuticals Inc (DRNA) Stock News